Increasing breast cancer prevalence & incidences, growing awareness of patients toward the connection of breast density, and rising radiology demand for treating breast cancer are fuelling the growth of Automated Breast Ultrasound System (ABUS) Market for the past few years. All these parameters are responsible for augmenting the growth of the Automated Breast Ultrasound System (ABUS) Market in upcoming years. Recent advancements in ABUS systems help higher-frequency transducers to facilitate the reproduction of superior quality images within short time period. The ABUS provides high features in cancer detection by providing detection rate, image quality, higher sensitivity, and diagnostic accuracy rates. This system contributes to handling comfort, accuracy, and time-efficiency in various research activities. ABUS is a reproducible system and obtains high resolution through three-dimensional imaging. Mammography technology has presented promising results in the detection of tumors in women with the help of ultrasound techniques.Īutomated breast ultrasound (ABUS) is a recent technology developed in the field of ultrasound imaging that is developed to obtain an operator-independent system. Well-established technologies such as Mammography and ultrasound are used for screening and early detection of breast cancer.

In order to reduce the morbidity & mortality rates and increase survival chances, healthcare providers focus on its early detection. It has spread worldwide and is a serious health concern as it is the major type of cancer found in the female population. The most common form of cancer found in women is breast cancer. According to vantage market research, the Global Automated Breast Ultrasound System (ABUS) market is valued at USD 705.5 Million in 2021 and is projected to attain a value of USD 1807.3 Million by 2028 at a CAGR of 15.9% during the forecast period, 2022–2028.

Qview medical revenue